These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 22166985)

  • 1. Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.
    Cryer PE
    Endocrinology; 2012 Mar; 153(3):1039-48. PubMed ID: 22166985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of epinephrine-mediated beta-adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in insulin-dependent diabetes mellitus.
    Popp DA; Shah SD; Cryer PE
    J Clin Invest; 1982 Feb; 69(2):315-26. PubMed ID: 6120181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-impairment of autonomic and glucagon responses to insulin-induced hypoglycemia in dogs with naturally occurring insulin-dependent diabetes mellitus.
    Gilor C; Duesberg C; Elliott DA; Feldman EC; Mundinger TO; Taborsky GJ; Nelson RW; Havel PJ
    Am J Physiol Endocrinol Metab; 2020 Dec; 319(6):E1074-E1083. PubMed ID: 33044845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of α-Cells in Islet Function and Glucose Homeostasis in Health and Type 2 Diabetes.
    Gilon P
    J Mol Biol; 2020 Mar; 432(5):1367-1394. PubMed ID: 31954131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathways underlying the pathogenesis of pancreatic alpha-cell dysfunction.
    Kawamori D; Welters HJ; Kulkarni RN
    Adv Exp Med Biol; 2010; 654():421-45. PubMed ID: 20217508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes.
    Israelian Z; Gosmanov NR; Szoke E; Schorr M; Bokhari S; Cryer PE; Gerich JE; Meyer C
    Diabetes Care; 2005 Nov; 28(11):2691-6. PubMed ID: 16249541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glucagon in the pathogenesis of diabetes: the status of the controversy.
    Unger RH
    Metabolism; 1978 Nov; 27(11):1691-709. PubMed ID: 360007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin receptor type 2 antagonism improves glucagon counterregulation in biobreeding diabetic rats.
    Karimian N; Qin T; Liang T; Osundiji M; Huang Y; Teich T; Riddell MC; Cattral MS; Coy DH; Vranic M; Gaisano HY
    Diabetes; 2013 Aug; 62(8):2968-77. PubMed ID: 23630299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha cell dysfunction in type 1 diabetes.
    Yosten GLC
    Peptides; 2018 Feb; 100():54-60. PubMed ID: 29412832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon secretion from pancreatic α-cells.
    Briant L; Salehi A; Vergari E; Zhang Q; Rorsman P
    Ups J Med Sci; 2016 May; 121(2):113-9. PubMed ID: 27044683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
    Farhy LS; McCall AL
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1(0 1):133-43. PubMed ID: 21824267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of Glucagon Secretion by Hyperglycemia-Induced Sodium-Dependent Reduction of ATP Production.
    Knudsen JG; Hamilton A; Ramracheya R; Tarasov AI; Brereton M; Haythorne E; Chibalina MV; Spégel P; Mulder H; Zhang Q; Ashcroft FM; Adam J; Rorsman P
    Cell Metab; 2019 Feb; 29(2):430-442.e4. PubMed ID: 30415925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes.
    Omar-Hmeadi M; Lund PE; Gandasi NR; Tengholm A; Barg S
    Nat Commun; 2020 Apr; 11(1):1896. PubMed ID: 32312960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of glucagon secretion, their application to the analysis of the defects in glucagon counterregulation and potential extension to approximate glucagon action.
    Farhy LS; McCall AL
    J Diabetes Sci Technol; 2010 Nov; 4(6):1345-56. PubMed ID: 21129329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
    Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
    Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia.
    Asadi F; Dhanvantari S
    Front Endocrinol (Lausanne); 2021; 12():726368. PubMed ID: 34659118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose control of glucagon secretion-'There's a brand-new gimmick every year'.
    Gylfe E
    Ups J Med Sci; 2016 May; 121(2):120-32. PubMed ID: 27044660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular reductions in glucokinase activity increase counter-regulatory responses to hypoglycemia in mice and humans with diabetes.
    Chakera AJ; Hurst PS; Spyer G; Ogunnowo-Bada EO; Marsh WJ; Riches CH; Yueh CY; Markkula SP; Dalley JW; Cox RD; Macdonald IA; Amiel SA; MacLeod KM; Heisler LK; Hattersley AT; Evans ML
    Mol Metab; 2018 Nov; 17():17-27. PubMed ID: 30146176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.